Latest On Titan Pharmaceuticals, Inc (TTNP):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-12-15 17:03 EST | News | Titan Pharmaceuticals rises on plans of merger with undisclosed advanced air mobility player | N/A |  |
| 2022-12-12 20:41 EST | News | Titan inks licensing deal with Ocular Therapeutix for US region | N/A | |
| 2022-06-11 08:56 EST | News | Activist Investing discloses 9.9% stake in Titan Pharmaceuticals | N/A | |
| 2022-02-02 09:25 EST | News | Titan Pharmaceuticals to raise $5.5M in stock and pre-funded warrant offering | N/A | |
| 2021-12-21 10:00 EST | News | Titan Pharma to evaluate strategic alternatives | N/A | |
| 2021-10-26 03:07 EST | News | Titan Pharmaceuticals granted development funding from Gates Foundation | N/A | |
| 2021-10-12 14:10 EST | News | Warning: TTNP is at high risk of performing badly | N/A | |
| 2021-10-06 19:16 EST | News | TTNP is at high risk of performing badly | N/A | |
| 2021-10-01 00:14 EST | News | Warning: TTNP has been downgraded to Very Bearish | N/A | |
| 2021-07-22 04:31 EST | News | Titan Pharma reports positive TP-2021 implant results in animal model of chronic pruritus | N/A | |
| 2021-02-19 00:50 EST | Earnings Estimate | An EPS average of -$0.96 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2021-02-19 00:50 EST | Analyst Rating | The Analyst Target Price has increased from $0.8 to $11. | Buy | |
| 2021-01-15 16:34 EST | News | Titan Pharmaceuticals -3% on pricing of $9.7M direct offering | N/A | |
| 2020-12-16 13:05 EST | News | Titan Pharma regains Nasdaq listing compliance | N/A | |
| 2020-12-02 05:29 EST | News | Titan Pharmaceuticals announces 1-for-30 reverse stock split | N/A | |
| 2020-12-02 05:25 EST | Stock Split | A stock split has occured on Dec 1, 2020 with a split factor of 1:30. | Neutral | |
| 2020-11-26 21:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-21 13:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 13:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-03 11:25 EST | News | Titan Pharma closes debt settlement and JT-09 acquisition | N/A | |
| 2020-11-01 03:34 EST | News | Titan Pharmaceuticals to acquire JT Pharma's JT-09 | N/A | |
| 2020-11-01 03:33 EST | News | Titan Pharma to raise $8M in stock offering | N/A | |
| 2020-10-27 03:14 EST | News | Titan Pharmaceuticals inks agreement to settle its debt with Molteni and Horizon | N/A | |
| 2020-10-16 03:59 EST | News | Titan Pharmaceuticals issues strategic and corporate update | N/A | |
| 2020-09-26 14:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-25 02:12 EST | News | Titan Pharma prices $2.7M direct offering | N/A | |
| 2020-09-18 19:07 EST | News | Titan Pharmaceuticals' increases authorized shares | N/A | |
| 2020-09-17 06:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-16 02:28 EST | News | Titan Pharma inks distribution pact with Accord for opioid addiction med | N/A | |
| 2020-08-18 13:54 EST | Analyst Rating | The Analyst Target Price has decreased from $1 to $0.8. | Neutral | |
| 2020-08-17 05:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-17 01:54 EST | Earnings Estimate | An EPS average of -$0.03 is estimated for the quarter ending on September 30, 2020. | Buy | |
| 2020-08-15 06:43 EST | News | Titan Pharmaceuticals EPS misses by $0.01, beats on revenue | N/A | |
| 2020-08-15 06:43 EST | News | Titan Pharma top-line up 160% | N/A | |
| 2020-08-15 06:42 EST | News | Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call Transcript | N/A | |
| 2020-08-14 10:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 09:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:05 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 18:43 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:00 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-24 19:10 EST | News | Titan Pharma teams up with Indegene for co-promotion of Probuphine | N/A | |
| 2020-06-19 13:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 05:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 06:45 EST | Financials | Company financials have been released. | Neutral | |
About Titan Pharmaceuticals, Inc (TTNP):
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company also develops ProNeura-Ropinirole, an implant to provide delivery of ropinirole, a dopamine agonist for the treatment of Parkinson's disease; and triiodothyronine, an implant for the treatment of hypothyroidism. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.
General
- Name Titan Pharmaceuticals, Inc
- Symbol TTNP
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 21
- Last Split Factor1:30
- Last Split Date2020-12-01
- Fiscal Year EndDecember
- IPO Date1996-01-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryPharmaceuticals
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.titanpharm.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 1.83
- Price/Book (Most Recent Quarter) 14.52
- Enterprise Value Revenue 6.92
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.02
- Operating Margin -342%
- Return on Assets -160%
- Revenue 5 million
- Earnings Per Share -$0.93
- Revenue Per Share $1.85
- Gross Profit -4919000
- Quarterly Earnings Growth 18.3%
View More
Highlights
- Market Capitalization 31.76 million
- EBITDA -14106000
- PE Ratio -1.2
- Analyst Target Price $11
- Book Value Per Share $0.02
View More
Share Statistics
- Shares Outstanding 9.86 million
- Shares Float 5.29 million
- % Held by Insiders 508%
- % Held by Institutions 3.53%
- Shares Short 1.58 million
- Shares Short Prior Month 1.31 million
- Short Ratio 0.55
- Short % of Float 16%
- Short % of Shares Outstanding 16%
View More
Technicals
- Beta 0.96
- 52 Week High $14.06
- 52 Week Low $2.56
- 50 Day Moving Average 3.43
- 200 Day Moving Average 4.05
View More
Dividends
- Dividend Date 2020-12-01
- ExDividend Date N/A
- Dividend Yield 0%
View More
Titan Pharmaceuticals, Inc (TTNP) Dividend Calendar:
TTNP's last dividend payment was made to shareholders on December 1, 2020.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Titan Pharmaceuticals, Inc (TTNP) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-16 | $N/A | -$1.50 | -$1.05 | -42.86% |
| 2020-06-30 | 2020-08-14 | $N/A | -$1.50 | -$1.05 | -42.86% |
| 2020-03-31 | 2020-05-15 | $1.34 million | -$2.10 | ||
| 2019-12-31 | 2020-03-30 | $N/A | -$2.40 | -$2.40 | 0% |
| 2019-09-30 | 2019-11-14 | $947000 | -$5.40 | -$6.45 | 16.28% |
| 2019-06-30 | 2019-08-14 | $502000 | -$11.40 | -$7.95 | -43.4% |
| 2019-03-31 | 2019-05-15 | $945000 | -$10.20 | -$7.80 | -30.77% |
| 2018-12-31 | 2018-12-31 | $1.24 million | -$0.29 | -$0.31 | 6.45% |
| 2018-09-30 | 2018-11-14 | $1.65 million | -$19.80 | -$24.30 | 18.52% |
| 2018-06-30 | 2018-08-14 | $2.67 million | -$7.20 | -$27.00 | 73.33% |
| 2018-03-31 | 2018-05-15 | $1.06 million | -$21.60 | -$23.40 | 7.69% |
| 2017-09-30 | 2017-11-09 | $40000 | -$36.00 | -$25.20 | -42.86% |
| 2017-06-30 | 2017-08-09 | $77000 | -$28.80 | -$24.30 | -18.52% |
| 2017-03-31 | 2017-05-10 | $40000 | -$25.20 | -$27.00 | 6.67% |
| 2016-12-31 | 2017-03-16 | $35000 | -$19.80 | -$18.00 | -10% |
| 2016-09-30 | 2016-11-09 | $26000 | -$21.60 | -$19.80 | -9.09% |
| 2016-06-30 | 2016-08-09 | $15 million | $99.00 | $107.10 | -7.56% |
| 2016-03-31 | 2016-05-10 | $N/A | -$16.20 | -$20.70 | 21.74% |
| 2015-12-31 | 2016-03-15 | $1.67 million | -$19.80 | -$21.60 | 8.33% |
| 2015-09-30 | 2015-11-16 | $-760000 | -$0.09 | -$0.11 | 18.18% |
| 2015-06-30 | 2015-08-13 | $760000 | -$0.11 | -$0.05 | -120% |
| 2015-03-31 | 2015-05-13 | $911000 | -$0.22 | -$0.05 | -340% |
| 2014-12-31 | 2015-03-31 | $912000 | -$0.05 | -$0.05 | 0% |
| 2014-09-30 | 2014-11-13 | $911000 | $0.06 | -$0.05 | 220% |
| 2014-06-30 | 2014-08-13 | $912000 | -$0.33 | -$0.33 | 0% |
| 2014-03-31 | 2014-05-14 | $911000 | -$20.08 | ||
| 2013-09-30 | 2013-11-14 | $2.2 million | -$1.62 | ||
| 2013-06-30 | 2013-08-15 | $2.2 million | -$3.57 | ||
| 2013-03-31 | 2013-05-15 | $5.17 million | $2.31 | -$0.33 | 800% |
| 2012-12-31 | 2013-03-15 | $3.26 million | -$4.15 | ||
| 2012-09-30 | 2012-11-12 | $1.23 million | -$118.69 | ||
| 2012-06-30 | 2012-08-10 | $1.36 million | -$26.26 | ||
| 2012-03-31 | 2012-05-11 | $1.27 million | -$86.07 | ||
| 2011-12-31 | 2012-03-20 | $1.41 million | -$48.36 | ||
| 2011-09-30 | 2011-11-15 | $1.01 million | -$13.40 | ||
| 2011-06-30 | 2011-08-16 | $695000 | -$116.73 | ||
| 2011-03-31 | 2011-05-16 | $948000 | -$75.39 | ||
| 2010-12-31 | 2011-03-24 | $2.73 million | -$51.10 | ||
| 2010-09-30 | 2010-11-15 | $3.6 million | -$6.42 | ||
| 2010-06-30 | 2010-08-16 | $1.34 million | -$30.85 | ||
| 2010-03-31 | 2010-05-17 | $2.43 million | -$5.10 | ||
| 2008-12-31 | 2009-03-11 | $73000 | -$104.07 | ||
| 2008-09-30 | 2008-11-10 | $-12000 | -$3.30 | -$3.30 | 0% |
| 2008-06-30 | 2008-08-11 | $12000 | -$4.29 | -$3.63 | -18.18% |
| 2008-03-31 | 2008-05-12 | $61000 | -$3.30 | -$3.63 | 9.09% |
| 2007-12-31 | 2008-03-12 | $12000 | -$4.62 | -$3.30 | -40% |
| 2007-09-30 | 2007-11-08 | $-12000 | -$3.30 | -$2.97 | -11.11% |
| 2007-06-30 | 2007-08-02 | $12000 | -$2.64 | -$2.64 | 0% |
| 2007-03-31 | 2007-05-09 | $N/A | -$2.97 | -$4.29 | 30.77% |
| 2006-12-31 | 2007-03-05 | $29000 | -$2.97 | -$5.28 | 43.75% |
| 2006-09-30 | 2006-11-09 | $1000 | -$3.63 | -$2.97 | -22.22% |
| 2006-06-30 | 2006-08-09 | $1000 | -$2.97 | -$4.29 | 30.77% |
| 2006-03-31 | 2006-05-08 | $1000 | -$4.29 | -$6.60 | 35% |
| 2005-12-31 | 2006-03-14 | $61000 | -$3.96 | -$6.27 | 36.84% |
| 2005-09-30 | 2005-11-09 | $1000 | -$6.60 | -$7.59 | 13.04% |
| 2005-06-30 | 2005-08-09 | $13000 | -$5.94 | -$5.61 | -5.88% |
| 2005-03-31 | 2005-05-10 | $14000 | -$6.27 | -$6.93 | 9.52% |
| 2004-12-31 | 2005-03-14 | $30000 | -$7.92 | -$6.60 | -20% |
| 2004-09-30 | 2004-11-09 | $N/A | -$6.60 | -$8.58 | 23.08% |
| 2004-06-30 | 2004-08-09 | $-1000 | -$5.61 | -$7.59 | 26.09% |
| 2004-03-31 | 2004-05-06 | $1000 | -$7.26 | -$7.92 | 8.33% |
| 2003-12-31 | 2004-03-11 | $61000 | -$7.92 | -$7.59 | -4.35% |
| 2003-09-30 | 2003-11-14 | $-2000 | -$7.26 | -$7.92 | 8.33% |
| 2003-06-30 | 2003-08-11 | $2000 | -$7.92 | -$7.59 | -4.35% |
| 2003-03-31 | 2003-05-15 | $26000 | -$7.92 | -$7.26 | -9.09% |
| 2002-12-31 | 2003-03-27 | $236000 | -$10.56 | -$9.90 | -6.67% |
| 2002-09-30 | 2002-11-14 | $158000 | -$8.58 | -$8.83 | 2.83% |
| 2002-06-30 | 2002-08-12 | $151000 | -$8.25 | -$8.58 | 3.85% |
| 2002-03-31 | 2002-05-14 | $2.35 million | -$5.94 | -$6.02 | 1.33% |
| 2001-12-31 | 2002-03-28 | $589000 | -$7.59 | -$7.59 | 0% |
| 2001-09-30 | 2001-11-15 | $530000 | -$5.61 | -$5.69 | 1.41% |
| 2001-06-30 | 2001-08-15 | $2.87 million | -$2.31 | -$4.82 | 52.07% |
| 2001-03-31 | 2001-05-15 | $580000 | -$5.28 | -$4.70 | -12.34% |
| 2000-12-31 | 2001-03-22 | $569000 | -$4.95 | -$5.20 | 4.81% |
| 2000-09-30 | 2000-11-14 | $695000 | -$4.62 | -$5.77 | 19.93% |
| 2000-06-30 | 2000-08-15 | $281000 | -$2.97 | -$3.30 | 10% |
| 2000-03-31 | 2000-05-15 | $335000 | -$4.95 | -$4.29 | -15.38% |
| 1999-12-31 | 2000-03-23 | -$4.95 | -$4.07 | -21.62% | |
| 1999-09-30 | 1999-11-15 | -$5.28 | -$4.62 | -14.29% | |
| 1999-06-30 | 1999-08-16 | -$6.60 | -$6.10 | -8.2% | |
| 1999-03-31 | 1999-05-17 | -$6.27 | -$5.94 | -5.56% | |
| 1998-12-31 | 1999-03-31 | -$8.25 | -$7.09 | -16.36% | |
| 1998-09-30 | 1998-12-01 | -$6.93 | -$6.93 | 0% | |
| 1998-06-30 | 1998-08-17 | -$5.61 | -$8.74 | 35.81% | |
| 1998-03-31 | 1998-04-01 | -$10.23 | -$10.06 | -1.69% | |
| 1997-12-31 | 1998-03-31 | -$10.23 | -$10.06 | -1.69% |
Titan Pharmaceuticals, Inc (TTNP) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Titan Pharmaceuticals, Inc (TTNP) Chart:
Titan Pharmaceuticals, Inc (TTNP) News:
Below you will find a list of latest news for Titan Pharmaceuticals, Inc (TTNP) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Titan Pharmaceuticals, Inc (TTNP) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 0.05 | CALL | 1 | 20 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 4.6 | PUT | 0 | 1 | 267.99 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.05 | CALL | 1 | 5 | 169.97 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 0 | TRUE | 0 | 0 |
Latest TTNP Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 6:50 PM EST | 100 | $0.52 |
| Jun 13, 2022 7:04 PM EST | 100 | $0.5099 |
Titan Pharmaceuticals, Inc (TTNP) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920078070/0001104659-20-078070-index.htm |
| 2018-08-21 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/910267/000000000018025963/0000000000-18-025963-index.htm |
| 2019-04-15 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/910267/000000000019007162/0000000000-19-007162-index.htm |
| 2019-09-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/910267/000000000019013620/0000000000-19-013620-index.htm |
| 2019-10-22 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/910267/000090266419004033/0000902664-19-004033-index.htm |
| 2020-01-27 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/910267/000090266420000479/0000902664-20-000479-index.htm |
| 2019-10-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000110465919054586/0001104659-19-054586-index.htm |
| 2019-10-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465919054978/0001104659-19-054978-index.htm |
| 2019-11-04 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465919059094/0001104659-19-059094-index.htm |
| 2019-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/910267/000110465919064166/0001104659-19-064166-index.htm |
| 2019-11-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465919065596/0001104659-19-065596-index.htm |
| 2019-12-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465919071378/0001104659-19-071378-index.htm |
| 2019-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465919075090/0001104659-19-075090-index.htm |
| 2019-12-23 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465919075465/0001104659-19-075465-index.htm |
| 2019-12-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465919076943/0001104659-19-076943-index.htm |
| 2020-01-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000110465920002003/0001104659-20-002003-index.htm |
| 2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920002040/0001104659-20-002040-index.htm |
| 2020-01-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000110465920002046/0001104659-20-002046-index.htm |
| 2020-01-09 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/910267/000110465920002692/0001104659-20-002692-index.htm |
| 2020-01-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920004815/0001104659-20-004815-index.htm |
| 2020-01-21 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465920005614/0001104659-20-005614-index.htm |
| 2020-01-31 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465920009232/0001104659-20-009232-index.htm |
| 2020-01-31 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920009315/0001104659-20-009315-index.htm |
| 2020-02-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920017539/0001104659-20-017539-index.htm |
| 2020-02-19 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920022657/0001104659-20-022657-index.htm |
| 2020-02-24 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920024286/0001104659-20-024286-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920027674/0001104659-20-027674-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920034140/0001104659-20-034140-index.htm |
| 2020-03-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920035935/0001104659-20-035935-index.htm |
| 2020-03-30 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/910267/000110465920040354/0001104659-20-040354-index.htm |
| 2020-04-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920051001/0001104659-20-051001-index.htm |
| 2020-05-12 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465920060233/0001104659-20-060233-index.htm |
| 2020-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/910267/000110465920062136/0001104659-20-062136-index.htm |
| 2020-05-22 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465920065484/0001104659-20-065484-index.htm |
| 2020-06-19 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920074741/0001104659-20-074741-index.htm |
| 2020-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920076573/0001104659-20-076573-index.htm |
| 2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920078066/0001104659-20-078066-index.htm |
| 2020-06-30 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920078070/0001104659-20-078070-index.htm |
| 2020-07-08 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920082100/0001104659-20-082100-index.htm |
| 2020-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920084040/0001104659-20-084040-index.htm |
| 2020-07-16 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920084041/0001104659-20-084041-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920090511/0001104659-20-090511-index.htm |
| 2020-08-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920090512/0001104659-20-090512-index.htm |
| 2020-08-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920093801/0001104659-20-093801-index.htm |
| 2020-08-12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920093802/0001104659-20-093802-index.htm |
| 2020-08-13 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920094278/0001104659-20-094278-index.htm |
| 2020-08-13 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920094279/0001104659-20-094279-index.htm |
| 2020-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/910267/000110465920095091/0001104659-20-095091-index.htm |
| 2020-08-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920096969/0001104659-20-096969-index.htm |
| 2020-09-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920100978/0001104659-20-100978-index.htm |
| 2020-09-01 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920100979/0001104659-20-100979-index.htm |
| 2020-09-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920104869/0001104659-20-104869-index.htm |
| 2020-09-14 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/910267/000110465920104870/0001104659-20-104870-index.htm |
| 2020-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920106533/0001104659-20-106533-index.htm |
| 2020-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920108367/0001104659-20-108367-index.htm |
| 2020-09-25 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000110465920108489/0001104659-20-108489-index.htm |
| 2020-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920115280/0001104659-20-115280-index.htm |
| 2020-10-19 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000110465920116128/0001104659-20-116128-index.htm |
| 2020-10-23 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465920117763/0001104659-20-117763-index.htm |
| 2020-10-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920117956/0001104659-20-117956-index.htm |
| 2020-10-26 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000110465920117957/0001104659-20-117957-index.htm |
| 2020-10-27 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000110465920118552/0001104659-20-118552-index.htm |
| 2020-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920118991/0001104659-20-118991-index.htm |
| 2020-10-29 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000110465920119567/0001104659-20-119567-index.htm |
| 2020-11-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000110465920120516/0001104659-20-120516-index.htm |
| 2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000110465920120526/0001104659-20-120526-index.htm |
| 2018-05-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418029218/0001144204-18-029218-index.htm |
| 2018-05-23 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418030506/0001144204-18-030506-index.htm |
| 2018-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418031721/0001144204-18-031721-index.htm |
| 2018-06-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418032382/0001144204-18-032382-index.htm |
| 2018-07-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000114420418036970/0001144204-18-036970-index.htm |
| 2018-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418041056/0001144204-18-041056-index.htm |
| 2018-08-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418041882/0001144204-18-041882-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418042773/0001144204-18-042773-index.htm |
| 2018-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/910267/000114420418044671/0001144204-18-044671-index.htm |
| 2018-08-14 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420418044769/0001144204-18-044769-index.htm |
| 2018-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418045343/0001144204-18-045343-index.htm |
| 2018-09-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418047697/0001144204-18-047697-index.htm |
| 2018-09-04 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/910267/000114420418047698/0001144204-18-047698-index.htm |
| 2018-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418048734/0001144204-18-048734-index.htm |
| 2018-09-10 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/910267/000114420418048736/0001144204-18-048736-index.htm |
| 2018-09-12 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420418049103/0001144204-18-049103-index.htm |
| 2018-09-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420418049988/0001144204-18-049988-index.htm |
| 2018-09-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420418049990/0001144204-18-049990-index.htm |
| 2018-09-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418050015/0001144204-18-050015-index.htm |
| 2018-09-20 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420418050033/0001144204-18-050033-index.htm |
| 2018-09-25 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/910267/000114420418050585/0001144204-18-050585-index.htm |
| 2018-09-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418050743/0001144204-18-050743-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418050778/0001144204-18-050778-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418050779/0001144204-18-050779-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418050780/0001144204-18-050780-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418050781/0001144204-18-050781-index.htm |
| 2018-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418050782/0001144204-18-050782-index.htm |
| 2018-09-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418050965/0001144204-18-050965-index.htm |
| 2018-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418052332/0001144204-18-052332-index.htm |
| 2018-10-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420418054751/0001144204-18-054751-index.htm |
| 2018-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420418054795/0001144204-18-054795-index.htm |
| 2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/910267/000114420418059914/0001144204-18-059914-index.htm |
| 2018-12-06 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000114420418063197/0001144204-18-063197-index.htm |
| 2018-12-20 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/910267/000114420418065476/0001144204-18-065476-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419002680/0001144204-19-002680-index.htm |
| 2019-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419007517/0001144204-19-007517-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419009816/0001144204-19-009816-index.htm |
| 2019-02-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420419009921/0001144204-19-009921-index.htm |
| 2019-02-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420419009923/0001144204-19-009923-index.htm |
| 2019-04-01 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/910267/000114420419017459/0001144204-19-017459-index.htm |
| 2019-04-02 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/910267/000114420419017559/0001144204-19-017559-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420419018017/0001144204-19-018017-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420419018018/0001144204-19-018018-index.htm |
| 2019-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419018020/0001144204-19-018020-index.htm |
| 2019-04-05 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420419018434/0001144204-19-018434-index.htm |
| 2019-04-16 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420419019741/0001144204-19-019741-index.htm |
| 2019-04-23 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419020775/0001144204-19-020775-index.htm |
| 2019-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419021361/0001144204-19-021361-index.htm |
| 2019-04-26 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000114420419021363/0001144204-19-021363-index.htm |
| 2019-05-15 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/910267/000114420419026546/0001144204-19-026546-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/910267/000114420419030297/0001144204-19-030297-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419032717/0001144204-19-032717-index.htm |
| 2019-08-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000114420419038607/0001144204-19-038607-index.htm |
| 2019-08-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000114420419038634/0001144204-19-038634-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419038636/0001144204-19-038636-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/910267/000114420419040066/0001144204-19-040066-index.htm |
| 2019-08-19 | D | Notice of Exempt Offering of Securities | https://www.sec.gov/Archives/edgar/data/910267/000114420419040674/0001144204-19-040674-index.htm |
| 2019-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419041326/0001144204-19-041326-index.htm |
| 2019-09-12 | S-1 | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420419044334/0001144204-19-044334-index.htm |
| 2019-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419045089/0001144204-19-045089-index.htm |
| 2019-09-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/910267/000114420419045386/0001144204-19-045386-index.htm |
| 2019-09-27 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420419046325/0001144204-19-046325-index.htm |
| 2019-10-01 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419046785/0001144204-19-046785-index.htm |
| 2019-10-02 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419046871/0001144204-19-046871-index.htm |
| 2019-10-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419047153/0001144204-19-047153-index.htm |
| 2019-10-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419047383/0001144204-19-047383-index.htm |
| 2019-10-04 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419047407/0001144204-19-047407-index.htm |
| 2019-10-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419047521/0001144204-19-047521-index.htm |
| 2019-10-08 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420419047699/0001144204-19-047699-index.htm |
| 2019-10-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419047811/0001144204-19-047811-index.htm |
| 2019-10-09 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419047814/0001144204-19-047814-index.htm |
| 2019-10-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419047954/0001144204-19-047954-index.htm |
| 2019-10-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419048047/0001144204-19-048047-index.htm |
| 2019-10-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419048049/0001144204-19-048049-index.htm |
| 2019-10-11 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000114420419048088/0001144204-19-048088-index.htm |
| 2019-10-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419048091/0001144204-19-048091-index.htm |
| 2019-10-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419048102/0001144204-19-048102-index.htm |
| 2019-10-11 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/910267/000114420419048103/0001144204-19-048103-index.htm |
| 2019-08-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/910267/000153561019000094/0001535610-19-000094-index.htm |
| 2020-01-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/910267/000153561020000030/0001535610-20-000030-index.htm |
| 2020-09-24 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/910267/000153561020000113/0001535610-20-000113-index.htm |
| 2020-10-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/910267/000155335020000907/0001553350-20-000907-index.htm |
| 2018-08-30 | S-1/A | General form for registration of securities under the Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/910267/000157104918000460/0001571049-18-000460-index.htm |
| 2018-09-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/910267/000157104918000485/0001571049-18-000485-index.htm |
| 2018-09-20 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/910267/999999999518002418/9999999995-18-002418-index.htm |
| 2019-04-24 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/910267/999999999519000814/9999999995-19-000814-index.htm |
| 2019-10-16 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/910267/999999999519002323/9999999995-19-002323-index.htm |
| 2020-10-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/910267/999999999520003013/9999999995-20-003013-index.htm |
| 2018-06-15 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/910267/999999999718006406/9999999997-18-006406-index.htm |
| 2018-09-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/910267/999999999718007779/9999999997-18-007779-index.htm |
| 2018-09-11 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/910267/999999999718007780/9999999997-18-007780-index.htm |
| 2019-09-20 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/910267/999999999719006921/9999999997-19-006921-index.htm |
Titan Pharmaceuticals, Inc (TTNP) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Titan Pharmaceuticals, Inc (TTNP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 508%Institutional Ownership: 353%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-09-21 | M DAVID MACFARLANE | Director | Buy | 80,000.00 | 0.25 | 20,000.00 | 102,275.00 | https://www.sec.gov/Archives/edgar/data/910267/000114420418050782/0001144204-18-050782-index.htm |
| 2018-09-21 | Joseph A Akers | Director | Buy | 200,000.00 | 0.25 | 50,000.00 | 213,000.00 | https://www.sec.gov/Archives/edgar/data/910267/000114420418050778/0001144204-18-050778-index.htm |
| 2018-09-21 | JAMES R MCNAB | Director | Buy | 200,000.00 | 0.25 | 50,000.00 | 300,000.00 | https://www.sec.gov/Archives/edgar/data/910267/000114420418050780/0001144204-18-050780-index.htm |
| 2018-09-21 | SUNIL BHONSLE | Officer | Buy | 300,000.00 | 0.25 | 75,000.00 | 435,578.00 | https://www.sec.gov/Archives/edgar/data/910267/000114420418050781/0001144204-18-050781-index.htm |
| 2018-09-21 | Marc Rubin | Executive Chairman | Buy | 400,000.00 | 0.25 | 100,000.00 | 556,317.00 | https://www.sec.gov/Archives/edgar/data/910267/000114420418050779/0001144204-18-050779-index.htm |
| 2018-09-24 | Federico Seghi Recli | Director | Buy | 500,000.00 | 600,845.00 | https://www.sec.gov/Archives/edgar/data/910267/000114420418050965/0001144204-18-050965-index.htm | ||
| 2018-10-19 | Federico Seghi Recli | Director | Buy | 200,000.00 | 800,845.00 | https://www.sec.gov/Archives/edgar/data/910267/000114420418054751/0001144204-18-054751-index.htm |